Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation
- PMID: 20185054
- PMCID: PMC3057430
- DOI: 10.1016/j.jacc.2010.01.001
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation
Figures



Comment in
-
Macroscopic T-wave alternans: the tip of the iceberg in drug-induced torsade de pointes?J Am Coll Cardiol. 2010 Jul 13;56(3):241; author reply 241-2. doi: 10.1016/j.jacc.2010.03.041. J Am Coll Cardiol. 2010. PMID: 20620750 No abstract available.
Similar articles
-
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.Circulation. 2010 Mar 2;121(8):1047-60. doi: 10.1161/CIRCULATIONAHA.109.192704. Epub 2010 Feb 8. Circulation. 2010. PMID: 20142454 Free PMC article. No abstract available.
-
Preventing torsades de pointes by careful cardiac monitoring in hospital settings.AACN Adv Crit Care. 2007 Jul-Sep;18(3):285-93. doi: 10.4037/15597768-2007-3007. AACN Adv Crit Care. 2007. PMID: 18019519 Review.
-
Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm.Heart. 1998 Apr;79(4):417-9. doi: 10.1136/hrt.79.4.417. Heart. 1998. PMID: 9616356 Free PMC article.
-
Recognizing and treating torsade de pointes.Crit Care Nurse. 1992 Jun;12(5):23-9. Crit Care Nurse. 1992. PMID: 1597061 No abstract available.
-
Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.J Anesth. 2017 Jun;31(3):413-423. doi: 10.1007/s00540-017-2314-6. Epub 2017 Feb 22. J Anesth. 2017. PMID: 28229241 Review.
Cited by
-
Electroimmunology and cardiac arrhythmia.Nat Rev Cardiol. 2021 Aug;18(8):547-564. doi: 10.1038/s41569-021-00520-9. Epub 2021 Mar 2. Nat Rev Cardiol. 2021. PMID: 33654273 Free PMC article. Review.
-
Atomoxetine-induced life-threatening long QT syndrome.Ir J Med Sci. 2013 Sep;182(3):535-7. doi: 10.1007/s11845-013-0925-y. Epub 2013 Feb 19. Ir J Med Sci. 2013. PMID: 23420381 No abstract available.
-
Top 20 drug - drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients.J Family Med Prim Care. 2020 Dec 31;9(12):6023-6040. doi: 10.4103/jfmpc.jfmpc_1060_20. eCollection 2020 Dec. J Family Med Prim Care. 2020. PMID: 33681037 Free PMC article.
-
QT interval dynamics in patients with ST-elevation MI.Front Cardiovasc Med. 2023 Jan 6;9:1056456. doi: 10.3389/fcvm.2022.1056456. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36684584 Free PMC article.
-
C-reactive Protein Elevation Is Associated With QTc Interval Prolongation in Patients Hospitalized With COVID-19.Front Cardiovasc Med. 2022 Jun 23;9:866146. doi: 10.3389/fcvm.2022.866146. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35811700 Free PMC article.
References
-
- Dessertenne F. La tachycardie ventriculaire á deux foyers opposes variables. Arch Mal Coeur Vaiss. 1966;59:263–72. - PubMed
-
- Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol. 1983;2:806–17. - PubMed
-
- Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136–44. - PubMed
-
- Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome: International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339:960–5. - PubMed
-
- Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866–74. - PubMed